- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
T2s Group Holding SA (T2S)
T2s Group Holding SA stock price live, this page displays CSE T2S stock exchange data. View the T2S premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the T2s Group Holding SA real time stock price chart below.
What Is the T2s Group Holding SA Stock Price Today?
The T2s Group Holding SA stock price today is 208.90.
What Is the Stock Symbol for T2s Group Holding SA?
The stock symbol for T2s Group Holding SA is "T2S."
What Stock Exchange Does T2s Group Holding SA Trade On?
T2s Group Holding SA is listed and trades on the Casablanca stock exchange.
Is T2s Group Holding SA a Good Stock to Buy?
Determining whether T2s Group Holding SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the T2S quote. (ISIN: MA0000012858)
What Is the T2s Group Holding SA Stock Price Today?
The T2s Group Holding SA stock price today is 208.90.
What Is the Stock Symbol for T2s Group Holding SA?
The stock symbol for T2s Group Holding SA is "T2S."
What Stock Exchange Does T2s Group Holding SA Trade On?
T2s Group Holding SA is listed and trades on the Casablanca stock exchange.
Is T2s Group Holding SA a Good Stock to Buy?
Determining whether T2s Group Holding SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the T2S quote. (ISIN: MA0000012858)
Casablanca
Currency in MAD
208.90
-0.10(-0.05%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
207.00
212.00
52 wk Range
190.10
267.55
T2S is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
207.00212.00
52 wk Range
190.10267.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
T2S Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
243.00
Upside
+16.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Price has fallen significantly over the last three months
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 243.00
(+16.32% Upside)
Earnings
Latest Release
Sep 30, 2026
EPS / Forecast
4.87 / --
Revenue / Forecast
1B / --
Compare T2S to Peers and Sector
Metrics to compare | T2S | Peers Peers - average of corresponding metrics from companies closely matching T2S: TTEN3, NTC, MFDG.I0000, SPWR, DND | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipT2SPeersSector |
|---|---|---|---|---|
P/E Ratio | 13.0x | 11.9x | −0.3x | |
PEG Ratio | - | 0.01 | 0.00 | |
Price/Book | 1.7x | 1.2x | 2.6x | |
Price / LTM Sales | 1.2x | 0.7x | 2.9x | |
Upside (Analyst Target) | 16.3% | 37.2% | 62.0% | |
Fair Value Upside | Unlock | 21.7% | 9.5% | Unlock |
T2S Group Holding distributes, installs, and maintains high-tech equipment, solutions, and services for healthcare professionals in Morocco and Africa. The company operates through the radiology and oncology, ORAS (operating rooms and hospital care), medical devices, laboratory instruments, laboratory reagents, digital systems, and after-sales services segments. It offers medical imaging and radiation therapy equipment, such as CT scanners, MRI scanners, conventional radiology systems, mammography systems, nuclear medicine equipment, radiation therapy accelerators, and radiation therapy robots; equipment for operating rooms, intensive care units, anesthesia systems, sterilization, neuro-navigation, and ultrasound; surgical robots, minimally invasive and laparoscopic surgical instruments, implantable devices, and consumables for diagnostic and therapeutic procedures in cardiology, radiology, oncology, gastrointestinal endoscopy, and urology; equipment and reagents for laboratories, as well as molecular biology solutions; radiopharmaceuticals, such as PET tracers, contrast agents, and healthcare products for nuclear medicine; hospital and pharmaceutical IT solutions; and technical services for the installation, maintenance, and support of critical medical equipment. It caters to private institutions, including structured private hospital groups, medical practices, clinical laboratories, and independent practitioners; public institutions, including public hospitals, university hospitals, and military hospitals; and ministries of health. The company was founded in 1992 and is based in Casablanca, Morocco. T2S Group Holding operates as a subsidiary of Trone Investment Holdings Limited.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the T2s Holding (T2S) Stock Price Today?
The T2s Holding stock price today is 208.90 MAD.
What Stock Exchange Does T2s Holding Trade On?
T2s Holding is listed and trades on the Casablanca Stock Exchange.
What Is the Stock Symbol for T2s Holding?
The stock symbol for T2s Holding is "T2S."
What Is the T2s Holding Market Cap?
As of today, T2s Holding market cap is 2.44B MAD.
What Is T2s Holding's Earnings Per Share (TTM)?
The T2s Holding EPS (TTM) is 9.25.
From a Technical Analysis Perspective, Is T2S a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has T2s Holding Stock Split?
T2s Holding has split 0 times.
What is the current trading status of T2s Holding (T2S)?
As of Oct 20, 2026, T2s Holding (T2S) is trading at a price of 208.90 MAD, with a previous close of 208.90 MAD. The stock has fluctuated within a day range of 207.00 MAD to 212.00 MAD, while its 52-week range spans from 190.10 MAD to 267.55 MAD.
What Is T2s Holding (T2S) Price Target According to Analysts?
The average 12-month price target for T2s Holding is 243.00 MAD, with a high estimate of 243 MAD and a low estimate of 243 MAD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +16.32% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.